Immunotherapeutic Vaccine for the Treatment of HPV-associated Cancers

Global BioPharma, Inc. (GBP) is a clinical-stage biotechnology company focused on the development of cancer immunotherapies that take advantage of the body's natural immune system, redirecting the immune responses to target tumors. Our technology use bioengineered live attenuated bacteria, Listeria monocytogenes (Lm), to actively suppress key components in the tumor microenvironment that contribute to tumor growth and shield cancer cells from immunological attack.